Jang J, Kang Y, Zofall M, Woo S, An S, Cho C
Nucleic Acids Res. 2024; 53(4).
PMID: 39676666
PMC: 11879132.
DOI: 10.1093/nar/gkae1229.
Cho C, Ganser C, Uchihashi T, Kato K, Song J
Commun Biol. 2023; 6(1):993.
PMID: 37770645
PMC: 10539301.
DOI: 10.1038/s42003-023-05373-1.
Fu J, Zhang J, Chen X, Liu Z, Yang X, He Z
Theranostics. 2023; 13(2):787-809.
PMID: 36632213
PMC: 9830439.
DOI: 10.7150/thno.78840.
Shukla S, Lazarchuk P, Pavlova M, Sidorova J
iScience. 2022; 25(12):105464.
PMID: 36404917
PMC: 9672403.
DOI: 10.1016/j.isci.2022.105464.
Liu H, Wen Q, Yan S, Zeng W, Zou Y, Liu Q
Biomolecules. 2022; 12(8).
PMID: 36008934
PMC: 9405547.
DOI: 10.3390/biom12081040.
Effect of chronic intermittent hypoxia-induced HIF-1α/ATAD2 expression on lung cancer stemness.
Hao S, Li F, Jiang P, Gao J
Cell Mol Biol Lett. 2022; 27(1):44.
PMID: 35672694
PMC: 9172155.
DOI: 10.1186/s11658-022-00345-5.
Yta7, a chromatin segregase regulated by the cell cycle machinery.
Bansal P, Kurat C
Mol Cell Oncol. 2022; 9(1):2039577.
PMID: 35308047
PMC: 8932914.
DOI: 10.1080/23723556.2022.2039577.
Evaluation of ATAD2 as a Potential Target in Hepatocellular Carcinoma.
Ekin U, Yuzugullu H, Ozen C, Korhan P, Bagirsakci E, Yilmaz F
J Gastrointest Cancer. 2021; 52(4):1356-1369.
PMID: 34738187
DOI: 10.1007/s12029-021-00732-9.
ATAD2 controls chromatin-bound HIRA turnover.
Wang T, Perazza D, Boussouar F, Cattaneo M, Bougdour A, Chuffart F
Life Sci Alliance. 2021; 4(12).
PMID: 34580178
PMC: 8500222.
DOI: 10.26508/lsa.202101151.
A CDK-regulated chromatin segregase promoting chromosome replication.
Chacin E, Bansal P, Reusswig K, Diaz-Santin L, Ortega P, Vizjak P
Nat Commun. 2021; 12(1):5224.
PMID: 34471130
PMC: 8410769.
DOI: 10.1038/s41467-021-25424-7.
Therapeutic Strategies Against Cancer Stem Cells in Esophageal Carcinomas.
Das P, Islam F, Smith R, Lam A
Front Oncol. 2021; 10:598957.
PMID: 33665161
PMC: 7921694.
DOI: 10.3389/fonc.2020.598957.
Long Non-Coding RNA CRNDE Promotes Colorectal Carcinoma Cell Progression and Paclitaxel Resistance by Regulating miR-126-5p/ATAD2 Axis.
Liu C, Hou J, Shan F, Wang L, Lu H, Ren T
Onco Targets Ther. 2020; 13:4931-4942.
PMID: 32581554
PMC: 7276211.
DOI: 10.2147/OTT.S237580.
Discovery of novel ATAD2 bromodomain inhibitors that trigger apoptosis and autophagy in breast cells by structure-based virtual screening.
Yao D, Zhang J, Wang J, Pan D, He Z
J Enzyme Inhib Med Chem. 2020; 35(1):713-725.
PMID: 32174193
PMC: 7144325.
DOI: 10.1080/14756366.2020.1740924.
The ATAD2/ANCCA homolog Yta7 cooperates with Scm3 to deposit Cse4 at the centromere in yeast.
Shahnejat-Bushehri S, Ehrenhofer-Murray A
Proc Natl Acad Sci U S A. 2020; 117(10):5386-5393.
PMID: 32079723
PMC: 7071854.
DOI: 10.1073/pnas.1917814117.
Knockdown of ATAD2 Inhibits Proliferation and Tumorigenicity Through the Rb-E2F1 Pathway and Serves as a Novel Prognostic Indicator in Gastric Cancer.
Zhou X, Ji H, Ye D, Li H, Liu F, Li H
Cancer Manag Res. 2020; 12:337-351.
PMID: 32021447
PMC: 6970255.
DOI: 10.2147/CMAR.S228629.
Structural basis of nucleosome assembly by the Abo1 AAA+ ATPase histone chaperone.
Cho C, Jang J, Kang Y, Watanabe H, Uchihashi T, Kim S
Nat Commun. 2019; 10(1):5764.
PMID: 31848341
PMC: 6917787.
DOI: 10.1038/s41467-019-13743-9.
Prognostic value of ATPase family, AAA+ domain containing 2 expression in human cancers: A systematic review and meta-analysis.
Han H, Huang Q, Huang L, Chang F, Diao Q
Medicine (Baltimore). 2019; 98(39):e17180.
PMID: 31574824
PMC: 6775384.
DOI: 10.1097/MD.0000000000017180.
ATAD2 is associated with malignant characteristics of pancreatic cancer cells.
Liu N, Funasaka K, Obayashi T, Miyahara R, Hirooka Y, Goto H
Oncol Lett. 2019; 17(3):3489-3494.
PMID: 30867788
PMC: 6396210.
DOI: 10.3892/ol.2019.9960.
MicroRNA-372 functions as a tumor suppressor in cell invasion, migration and epithelial-mesenchymal transition by targeting in renal cell carcinoma.
Ji S, Su X, Zhang H, Han Z, Zhao Y, Liu Q
Oncol Lett. 2019; 17(2):2400-2408.
PMID: 30719113
PMC: 6350190.
DOI: 10.3892/ol.2018.9871.
Androgen Receptor Deregulation Drives Bromodomain-Mediated Chromatin Alterations in Prostate Cancer.
Urbanucci A, Barfeld S, Kytola V, Itkonen H, Coleman I, Vodak D
Cell Rep. 2017; 19(10):2045-2059.
PMID: 28591577
PMC: 5675034.
DOI: 10.1016/j.celrep.2017.05.049.